MétaCan
Menu
Back to cohort
Record W2567613149 · doi:10.1158/1538-7445.am2015-5452

Abstract 5452: Inhibition of sodium-independent and sodium-dependent nucleobase transport activities by tyrosine kinase inhibitors

2015· article· en· W2567613149 on OpenAlexaff
Vijaya L. Damaraju, Michelle Kuzma, Carol E. Cass, Michael B. Sawyer

Bibliographic record

VenueCancer Research · 2015
Typearticle
Languageen
FieldMedicine
TopicChronic Lymphocytic Leukemia Research
Canadian institutionsAlberta Cancer Foundation
Fundersnot available
KeywordsGefitinibErlotinibSorafenibDasatinibPharmacologyLapatinibSunitinibVandetanibTyrosine-kinase inhibitorTyrosine kinaseChemistryIC50ImatinibMedicineBiochemistryCancer researchInternal medicineCancerIn vitroEpidermal growth factor receptorReceptor

Abstract

fetched live from OpenAlex

Abstract Inhibition of nucleobase transport activities by tyrosine kinase inhibitors (TKIs) has not been studied to date. Since many targeted TKIs are often combined with either capecitabine or 5-fluorouracil (5-FU) in treatment of various advanced cancers, we examined TKI effects on both equilibrative nucleobase transport (ENBT) and sodium-dependent nucleobase transport (SNBT) activities. Our goal was to study effects of TKIs on human ENBT and SNBT activities to explore potential TKI interactions with nucleobase chemotherapy drugs. Effects of TKIs on ENBT activities were investigated in normal human renal proximal tubule epithelial cells (hRPTECs). TKI effects on SNBT activities were assessed in a pig kidney cell line (LLC-PK1). We showed that TKIs inhibited both ENBT and SNBT activities to different extents. Gefitinib inhibited ENBT activity with an IC50 value of 0.7 μM thus indicating high sensitivity of ENBT to inhibition by gefitinib in hRPTECs. Erlotinib > sorafenib > imatinib > sunitinib inhibited ENBT with IC50 values of 15, 40, 60, 78 μM, respectively whereas dasatinib, lapatinib and vandetanib were not inhibitory at concentrations >100 μM. Similar studies in LLC-PK1 cells, which exhibit SNBT activity, showed that vandetanib was the most potent inhibitor followed by sorafenib > erlotinib > gefitinib > sunitinib > imatinib with IC50 values of 14, 25, 28, 40, 47 and 94 μM, respectively whereas dasatinib and lapatinib were not inhibitory at concentrations >100 μM. These results indicate inhibition of both ENBT and SNBT activities by exposure of cells to TKIs. These effects on nucleobase transport activities, which could be direct or indirect, suggest why regimens combining gefitinib and 5-FU have failed. Further studies should test all TKI classes for such inhibitory activities to assess potential effects on combination regimens using TKIs with nucleobase drugs such as 5-FU in cancer treatment. Citation Format: Vijaya L. Damaraju, Michelle Kuzma, Carol E. Cass, Michael B. Sawyer. Inhibition of sodium-independent and sodium-dependent nucleobase transport activities by tyrosine kinase inhibitors. [abstract]. In: Proceedings of the 106th Annual Meeting of the American Association for Cancer Research; 2015 Apr 18-22; Philadelphia, PA. Philadelphia (PA): AACR; Cancer Res 2015;75(15 Suppl):Abstract nr 5452. doi:10.1158/1538-7445.AM2015-5452

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.000
metaresearch head score (Gemma)0.000
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Bench or experimental · Consensus signal: Bench or experimental
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.004
Threshold uncertainty score0.015

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0000.000
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0000.000
Bibliometrics0.0000.000
Science and technology studies0.0000.000
Scholarly communication0.0000.000
Open science0.0000.000
Research integrity0.0000.000
Insufficient payload (model declined to judge)0.0040.001

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.059
GPT teacher head0.363
Teacher spread0.304 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designBench or experimental
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations0
Published2015
Admission routes1
Has abstractyes

Explore more

Same venueCancer ResearchSame topicChronic Lymphocytic Leukemia ResearchFrench-language works237,207